Please use this identifier to cite or link to this item: http://repositorio.cualtos.udg.mx:8080/jspui/handle/123456789/1376
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTorres Romero, Julio Cesar-
dc.contributor.authorLara Riegos, Julio César-
dc.contributor.authorEstrella Parra, Edgar Antonio-
dc.contributor.authorFernández Sánchez, Verónica-
dc.contributor.authorArana Argáez, Víctor Ermilo-
dc.contributor.authorUc Colli, Sushally-
dc.contributor.authorPeña Rico, Miguel Ángel-
dc.contributor.authorRamírez Camacho, Mario Alberto-
dc.contributor.authorPonce Regalado, María Dolores-
dc.contributor.authorÁlvarez Sánchez, María Elizbeth-
dc.date.accessioned2022-07-12T17:35:08Z-
dc.date.available2022-07-12T17:35:08Z-
dc.date.issued2021-06-
dc.identifier.citationTorres-Romero, J. C. , Lara-Riegos, J. C. , Parra, E. A. E. , Sánchez, V. F. , Arana-Argáez, V. E. , Uc-Colli, S., Peña-Rico, M. Á. , Ramírez-Camacho, M. A. , Regalado, M. D. P. , & Alvarez-Sánchez, M. E. (2020). Lipoproteomics: Methodologies and Analysis of Lipoprotein-Associated Proteins along with the Drug Intervention. In (Ed.), Drug Design - Novel Advances in the Omics Field and Applications. IntechOpen. https://doi.org/10.5772/intechopen.93634es, en
dc.identifier.isbn978-1-78985-201-1-
dc.identifier.isbn978-1-78984-753-6-
dc.identifier.isbn978-1-78984-752-9-
dc.identifier.otherhttps://doi.org/10.5772/intechopen.93634-
dc.identifier.urihttp://repositorio.cualtos.udg.mx:8080/jspui/handle/123456789/1376-
dc.descriptionCapítuloes, en
dc.description.abstractLipoproteins are specialized particles involved in the transport and distribution of hydrophobic lipids, as cholesterol and triglycerides, throughout the body. The lipoproteins exhibit a basic spherical shape as complexes of lipids and proteins, and these latter are known as apolipoproteins. Initially, the proteins associated with lipoproteins were recognized as integral or peripheral proteins that only maintain the dynamics and metabolism of lipoproteins. However, there exist many studies on different lipoproteins evidencing that the quantity and type of apolipoproteins and lipoprotein-associated proteins are diverse and could be associated with different lipoprotein function outcomes. Here, we summarized recent processes in the determination of apolipoproteins and lipoprotein-associated proteins profiles through a proteomic approach, analyzing the major methods available and are used to achieve this. We also discuss the relevance of these lipoproteomic analyses on the human disease outcomes.es, en
dc.language.isoenes, en
dc.publisherIndonesia International Institute for Life Sciences, Indonesiaes, en
dc.subjectlipoproteinses, en
dc.subjectlipoproteomices, en
dc.subjectproteomices, en
dc.subjecthigh density lipoproteins (HDL)es, en
dc.subjectmass spectrometry (MS)es, en
dc.titleLipoproteomics: Methodologies and Analysis of Lipoprotein-Associated Proteins along with the Drug Interventiones, en
dc.title.alternativeDrug Design - Novel Advances in the Omics Field and Applicationses, en
dc.typeBook chapteres, en
Appears in Collections:3205 Capítulo de libro y/o memoria en extenso

Files in This Item:
File Description SizeFormat 
Enlace a_Lipoproteomics Methodologies and Analysis of Lipoprotein-Associated Proteins.htmEnlace a publicación45.75 kBHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.